JP2008536825A5 - - Google Patents

Download PDF

Info

Publication number
JP2008536825A5
JP2008536825A5 JP2008504368A JP2008504368A JP2008536825A5 JP 2008536825 A5 JP2008536825 A5 JP 2008536825A5 JP 2008504368 A JP2008504368 A JP 2008504368A JP 2008504368 A JP2008504368 A JP 2008504368A JP 2008536825 A5 JP2008536825 A5 JP 2008536825A5
Authority
JP
Japan
Prior art keywords
phenyl
alkyl
piperidin
ethyl
ethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008504368A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008536825A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/011663 external-priority patent/WO2006105304A2/en
Publication of JP2008536825A publication Critical patent/JP2008536825A/ja
Publication of JP2008536825A5 publication Critical patent/JP2008536825A5/ja
Withdrawn legal-status Critical Current

Links

JP2008504368A 2005-03-31 2006-03-30 フェニルおよびピリジルlta4hモジュレータ Withdrawn JP2008536825A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66719905P 2005-03-31 2005-03-31
PCT/US2006/011663 WO2006105304A2 (en) 2005-03-31 2006-03-30 Phenyl and pyridyl lta4h modulators

Publications (2)

Publication Number Publication Date
JP2008536825A JP2008536825A (ja) 2008-09-11
JP2008536825A5 true JP2008536825A5 (enExample) 2009-05-14

Family

ID=36950133

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008504368A Withdrawn JP2008536825A (ja) 2005-03-31 2006-03-30 フェニルおよびピリジルlta4hモジュレータ

Country Status (17)

Country Link
US (1) US20060223792A1 (enExample)
EP (1) EP1868605A2 (enExample)
JP (1) JP2008536825A (enExample)
KR (1) KR20080003385A (enExample)
CN (1) CN101189012A (enExample)
AU (1) AU2006230379A1 (enExample)
BR (1) BRPI0607742A2 (enExample)
CA (1) CA2603122A1 (enExample)
CO (1) CO6382173A2 (enExample)
CR (1) CR9480A (enExample)
EA (1) EA200702128A1 (enExample)
IL (1) IL186432A0 (enExample)
MX (1) MX2007012235A (enExample)
NI (1) NI200700250A (enExample)
NO (1) NO20075429L (enExample)
WO (1) WO2006105304A2 (enExample)
ZA (1) ZA200709346B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3205644A1 (en) 2005-12-29 2017-08-16 Celtaxsys Inc. Diamine derivatives as inhibitors of leukotriene a4 hydrolase
JP2009269819A (ja) * 2006-08-25 2009-11-19 Asahi Kasei Pharma Kk アミン化合物
PT2268646E (pt) * 2008-04-11 2013-12-10 Janssen Pharmaceutica Nv Aminas de tiazolopiridina-2-iloxi-fenil e de tiazolopirazina-2-iloxi-fenilo como moduladores da hidrolase de leucotrieno a4
MX2011012190A (es) * 2009-05-14 2011-12-08 Janssen Pharmaceutica Nv Compuestos con dos porciones de heteroarilo biciclico fusionado como moduladores de la leucotrieno a4 hidrolasa.
AP3339A (en) 2011-03-14 2015-07-31 Boehringer Ingelheim Int Benzodioxane inhibitors of leukotriene production
US9139567B2 (en) 2011-07-19 2015-09-22 Boehringer Ingelheim International Gmbh Arylpyrazole ethers as inhibitors of leukotriene A4 hydrolase
FR2984730A1 (fr) * 2011-12-22 2013-06-28 Diverchim Nouvelles compositions cosmetiques anti-age et depigmentantes
JP6080226B2 (ja) 2012-03-06 2017-02-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 他の活性物質と組み合わせたロイコトリエン産生阻害用ベンゾジオキサン
AR091315A1 (es) 2012-03-06 2015-01-28 Boehringer Ingelheim Int Inhibidores de benzodioxano de la produccion de leucotrieno
WO2014014874A1 (en) 2012-07-17 2014-01-23 Boehringer Ingelheim International Gmbh Pyrazole derivatives which inhibit leukotriene production
AU2014249168B2 (en) 2013-03-12 2018-07-12 Celltaxis, Llc Methods of inhibiting leukotriene A4 hydrolase
MX2015011678A (es) 2013-03-14 2016-07-08 Celtaxsys Inc Inhibidores de leucotrieno a4 hidrolasa.
EP2968265A4 (en) * 2013-03-14 2016-12-28 Celtaxsys Inc INHIBITORS OF THE LEUKOTRIEN A4 HYDROLASE
AU2014240042C1 (en) 2013-03-14 2019-09-05 Celltaxis, Llc Inhibitors of leukotriene A4 hydrolase
JP2016523982A (ja) 2013-07-15 2016-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン生成の阻害剤
WO2015009609A1 (en) 2013-07-15 2015-01-22 Boehringer Ingelheim International Gmbh Inhibitors of leukotriene production
BR102013020313B1 (pt) * 2013-08-09 2021-07-06 Fundação Oswaldo Cruz derivados bifeniloxi-alquil-aminas e ariloxi-alquil-aminas, e, composição farmacêutica
JP2017503783A (ja) * 2013-12-19 2017-02-02 バイエル ファーマ アクチエンゲゼルシャフト アドレナリン受容体アルファ2c拮抗薬としての置換されたビピペリジニル誘導体
JP2017501164A (ja) 2013-12-19 2017-01-12 バイエル ファーマ アクチエンゲゼルシャフト 置換されたピペリジニルテトラヒドロキノリン類
SG11201604978QA (en) 2013-12-19 2016-07-28 Bayer Pharma AG Substituted piperidinyl-tetrahydroquinolines and their use as alpha-2c adrenoreceptor antagonists
CA2934134A1 (en) * 2013-12-19 2015-06-25 Bayer Pharma Aktiengesellschaft Substituted bipiperidinyl derivatives as adrenoreceptor alpha 2c antagonists
KR101499007B1 (ko) * 2014-04-24 2015-03-05 고려대학교 산학협력단 염증성 질환의 예방 또는 치료용 약학 조성물
EP3215489B1 (en) * 2014-11-03 2019-07-24 OLON S.p.A. Method for the preparation of 1-(2-halogen-ethyl)-4 piperidine-carboxylic acid ethyl esters
PT109740B (pt) * 2016-11-14 2020-07-30 Hovione Farmaciencia Sa Processo para a preparação de brometo de umeclidínio
CN119285538A (zh) 2017-05-04 2025-01-10 发现号收购集团 作为例如用于保护植物的害虫防治剂的2-{[2-(苯氧基甲基)吡啶-5-基]氧基}乙胺衍生物及相关化合物
EP3801559B1 (en) 2018-05-31 2025-01-01 Celltaxis, LLC Method of reducing pulmonary exacerbations in respiratory disease patients
TWI834581B (zh) * 2018-07-31 2024-03-01 瑞士商諾華公司 Lta4h抑制劑的晶型
CA3126021A1 (en) 2019-01-11 2020-07-16 Naegis Pharmaceuticals Inc. Leukotriene synthesis inhibitors
CN110229091B (zh) * 2019-06-21 2022-11-22 天津科技大学 具有白三烯a4水解酶抑制作用的1,5-二取代吲哚衍生物及应用
CN113683491A (zh) * 2021-09-01 2021-11-23 王传良 一种4-(2-溴乙基)苯酚的制备方法
CA3221177A1 (en) 2021-11-01 2023-05-04 Meghan Kerrisk Campbell Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases
CN116804675A (zh) * 2023-04-19 2023-09-26 广东省中医院(广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院) 特应性皮炎的生物标志物及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038412A (en) * 1975-08-25 1977-07-26 Richardson-Merrell Inc. N-(phenylether-substituted benzyl)alkanediamines
JPH0696532B2 (ja) * 1988-08-11 1994-11-30 山之内製薬株式会社 血小板活性化因子拮抗剤
JP2768008B2 (ja) * 1991-10-04 1998-06-25 大正製薬株式会社 アルコキシフェニルアルキルアミン誘導体
US5585492A (en) * 1994-10-11 1996-12-17 G. D. Searle & Co. LTA4 Hydrolase inhibitors
US6506876B1 (en) * 1994-10-11 2003-01-14 G.D. Searle & Co. LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
US5925654A (en) * 1997-03-12 1999-07-20 G.D. Searle & Co. LTA4 , hydrolase inhibitors
US6110944A (en) * 1997-03-12 2000-08-29 G. D. Searle & Co. LTA4, hydrolase inhibitors
AU2002222550A1 (en) * 2000-11-29 2002-06-11 Kyorin Pharmaceutical Co. Ltd. Substituted carboxylic acid derivatives
WO2005012296A1 (en) * 2003-07-28 2005-02-10 Janssen Pharmaceutica N.V. Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
AU2004268455B2 (en) * 2003-08-29 2009-12-17 Ono Pharmaceutical Co., Ltd. Compound capable of binding S1P receptor and pharmaceutical use thereof
US7825109B2 (en) * 2003-08-29 2010-11-02 Ono Pharmaceutical Co., Ltd. Compound capable of binding S1P receptor and pharmaceutical use thereof

Similar Documents

Publication Publication Date Title
KR100728665B1 (ko) 함질소 복소환 화합물 및 그 의약
TWI359140B (enExample)
JP2007500703A5 (enExample)
EP2314586B1 (en) 2-Acylaminothiazole derivative or salt thereof
ME02532B (me) Jedinjenja beta-laktama supstituisana amidinom, njihovo dobijanje i upotreba kao antibakterijskih sredstava
JP2010538076A5 (enExample)
CA3172387A1 (en) Indazole based compounds and associated methods of use
JP2006509715A5 (enExample)
RU2005131833A (ru) Азотсодержащие гетероциклические производные и лекарственные средства, содержащие их в качестве активного ингредиента
CA2796967A1 (en) Heterocyclic derivatives as alk inhibitors
JP2017525757A5 (enExample)
JP2020511452A5 (enExample)
JP2010520893A5 (enExample)
HRP20120738T1 (hr) Inhibitori kinaza akt i p70 s6
JP2008517926A5 (enExample)
JP2006506380A5 (enExample)
CA2585053A1 (en) Substituted n-acyl (hetero)aryl compounds as c-fms kinase inhibitors
JP2012530765A5 (enExample)
JP2022501342A5 (enExample)
JP2010526801A5 (enExample)
RU2006100190A (ru) Производные хинолиламида в качестве антагонистов ccr-5
KR20080003385A (ko) 페닐 및 피리딜 lta4h 조절제
JP2010536821A5 (enExample)
JP2005529842A5 (enExample)
JP2014510695A5 (enExample)